Detalhe da pesquisa
1.
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Blood
; 142(12): 1056-1070, 2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339579
2.
Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma.
J Biol Chem
; 299(6): 104814, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178919
3.
Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model.
Haematologica
; 108(9): 2513-2519, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727398
4.
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity.
Int J Biol Sci
; 19(14): 4644-4656, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781042
5.
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.
J Clin Invest
; 131(8)2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855973
6.
Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
Nat Cell Biol
; 22(11): 1396, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33033376
7.
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
Nat Cell Biol
; 22(10): 1264-1275, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929201
8.
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nat Commun
; 11(1): 673, 2020 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31996688
9.
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nat Commun
; 10(1): 5114, 2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31704972
10.
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
Cancer Cell
; 34(6): 954-969.e4, 2018 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537515
11.
C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse.
Mol Immunol
; 46(7): 1397-404, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167760
12.
Proteomic profiling of urinary protein excretion in the factor H-deficient mouse.
Am J Nephrol
; 26(2): 127-35, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16549904
13.
C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
J Am Soc Nephrol
; 16(12): 3572-82, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16207826
14.
Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells.
J Immunol
; 173(6): 4190-6, 2004 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15356170